| Name | Title | Contact Details |
|---|
At Flow, AI isnt just a feature—its the core of everything we do. We are transforming the wholesale insurance industry by building a futuristic insurance brokerage where AI powers every aspect of the experience. With advanced AI features already live in production and actively used by our brokers, we are pioneering Wholesale 3.0, equipping brokers with cutting-edge tools to provide unparalleled service. We are creating an ecosystem of AI agents designed to streamline processes and enhance decision-making in the insurance landscape. The industry relies heavily on text—emails, files, and documents—making Generative AI a perfect fit for solving its challenges. Flow leverages AI to deliver meaningful insights, deep analysis, and white-glove support for every transaction, no matter the deal size. By combining human expertise with Platformless AI, we are bringing back the art of wholesale insurance while eliminating the need for outdated portals. In the past seven months, weve grown 250% month-over-month(!) and are forecasting even more massive growth. Were a Series A startup with over $20M raised from top investors like Lightspeed, MunichRe Ventures, and industry angels.
American Freight Furniture & Mattress is a discount retailer based in the U.S., specializing in furniture, mattresses, and home appliances. Founded in 1994 in Lima, Ohio, the company has expanded to over 370 locations nationwide and serves more than 5 million customers. It operates under a warehouse-style model that emphasizes affordability and quality, offering direct-to-consumer sales. The product range includes living room sets, bedroom furniture, dining room pieces, mattresses, and a variety of home appliances such as refrigerators and washers. American Freight also provides same-day delivery for in-stock items. The company targets budget-conscious shoppers, including families and first-time homeowners, and features products from trusted brands. With a focus on cost efficiency, American Freight combines new and reconditioned inventory to maintain low prices, making quality home goods accessible to a wide audience.
Techmotive is a tech-enabled service provider established in 2012, based in Oahu, Hawaii. Our company specializes in re-calibrating Advanced Driver Assistance Systems (ADAS) for vehicles, primarily for collision centers. ADAS are systems within vehicles that assist drivers with driving and parking, enhancing safety and overall driving experience by using sensors, cameras, and software algorithms to monitor surroundings, detect potential hazards, and alert or take corrective actions as needed. With a heritage built on innovation, quality, and trust, Techmotive stands as a leader in the automotive service industry. We invite you to explore our services and experience the difference that Original Equipment (OE) and dedication to excellence can make.
We specialize in optimizing the Human Experience by providing insights, recommendations, intelligent automation, and cognitive self-assist capabilities. Interested in how our capabilities could help your company? Please contact us at info@actiohx.com and one of our subject matter experts will be in contact with you!
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.